Literatur
- 1
Treiber G.
Systemic treatment of hepatocellular carcinoma.
Dig
Dis.
2001;
19
311-323
- 2
Bruix J, Sherman M, Llovet J M, Beaugrand M, Lencioni R, Burroughs A K, Christensen E,
Pagliaro L, Colombo M, Rodes J.
Clinical management of hepatocellular carcinoma. Conclusions
of the Barcelona-2000 EASL conference. European Association for the Study of
the Liver.
J
Hepatol.
2001;
35
421-430
- 3
Mathurin P, Rixe O, Carbonell N, Bernard B, Cluzel P, Bellin M F, Khayat D, Opolon P,
Poynard T.
Review article: Overview of medical treatments in
unresectable hepatocellular carcinoma - an impossible
meta-analysis?.
Aliment Pharmacol
Ther.
1998;
12
111-126
- 4
Llovet J M, Bruix J.
Systematic review of randomized trials for unresectable
hepatocellular carcinoma: Chemoembolization improves
survival.
Hepatology.
2003;
37
429-442
- 5
Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos O N.
Treatment of hepatocellular carcinoma with octreotide: a
randomised controlled
study.
Gut.
1998;
42
442-447
- 6
Yuen M F, Poon R T, Lai C L, Fan S T, Lo C M, Wong K W, Wong W M, Wong B C.
A randomized placebo-controlled study of long-acting
octreotide for the treatment of advanced hepatocellular
carcinoma.
Hepatology.
2002;
36
687-691
- 7
Kawata S, Yamasaki E, Nagase T, Inui Y, Ito N, Matsuda Y, Inada M, Tamura S, Noda S,
Imai Y, Matsuzawa Y.
Effect of pravastatin on survival in patients with advanced
hepatocellular carcinoma. A randomized controlled trial.
Br J
Cancer.
2001;
84
886-891
- 8
Llovet J M, Real M I, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J,
Sola R, Rodes J, Bruix J.
Arterial embolisation or chemoembolisation versus symptomatic
treatment in patients with unresectable hepatocellular carcinoma: a randomised
controlled
trial.
Lancet.
2002;
359
1734-1739
- 9
Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A,
Cottone M.
Transarterial chemoembolization for unresectable
hepatocellular carcinoma: meta-analysis of randomized controlled
trials.
Radiology.
2002;
224
47-54
- 10
Clavien P A, Selzner N, Morse M, Selzner M, Paulson E.
Downstaging of hepatocellular carcinoma and liver metastases
from colorectal cancer by selective intra-arterial
chemotherapy.
Surgery.
2002;
131
433-442
- 11
Schwartz J D, Schwartz M, Mandeli J, Sung M.
Neoadjuvant and adjuvant therapy for resectable
hepatocellular carcinoma: review of the randomised clinical
trials.
Lancet
Oncol.
2002;
3
593-603
- 12
Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H.
Combination therapy with transcatheter arterial
chemoembolization and percutaneous ethanol injection compared with percutaneous
ethanol injection alone for patients with small hepatocellular carcinoma: a
randomized control
study.
Cancer.
2001;
92
1516-1524
Priv.-Doz. Dr. med. Stefan Kubicka
Abteilung Gastroenterologie, Hepatologie und
Endokrinologie
Medizinische Hochschule Hannover
Carl Neuberg Straße 1
30625 Hannover
Phone: 49/511/5326766
Fax: 49-511/5322021
Email: Kubicka.stefan@mh-hannover.de
